STARSIS Side Effects

6257343-9 | Hyponatraemia, Inappropriate Antidiuretic Hormone Secretion
on Jun 24, 2009 Male patient from JAPAN , 73 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Starsis (View Usage). Patient experienced the following unwanted or unexpected effects: hyponatraemia, inappropriate antidiuretic hormone secretion. Starsis dosage: 360 Mg/day. During the same period patient was treated with DOGMATYL (200mg Daily) (View Dogmatyl Review and Dogmatyl Label ), FAMOTIDINE (80 Mg, Unk) (View Famotidine Review and Famotidine Label ), LOXOPROFEN SODIUM (360 Mg, Unk) (View Loxoprofen Sodium Review and Loxoprofen Sodium Label ), SODIUM CHLORIDE (18 G, Unk) (View Sodium Chloride Review and Sodium Chloride Label ), MELBIN (1000 Mg, Unk) (View Melbin Review and Melbin Label ), ACINON (300 Mg, Unk) (View Acinon Review and Acinon Label ). Patient was hospitalized.

5984334-5 | Inappropriate Antidiuretic Hormone Secretion, Rash
Patient was taking Starsis (View Usage). Patient had the following side effects: inappropriate antidiuretic hormone secretion, rash (What is rash?) on Nov 28, 2008 from JAPAN Additional patient health information: Female patient , 70 years of age, was diagnosed with diabetes mellitus and. Starsis dosage: 270 Mg/day. During the same period patient was treated with RABEPRAZOLE SODIUM (10 Mg) (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), ASPIRIN (100 Mg) (View Aspirin Review and Aspirin Label ), ARTIST (2.5 Mg) (View Artist Review and Artist Label ), SIGMART (15 Mg) (View Sigmart Review and Sigmart Label ), GASMOTIN (15 Mg) (View Gasmotin Review and Gasmotin Label ), DIAZEPAM (4 Mg) (View Diazepam Review and Diazepam Label ).

5630102-3 | Abdominal Pain Upper, Nausea
Adverse event was reported on Feb 08, 2008 by a Female patient taking Starsis (View Usage) (Dosage: 180 Mg, Qd) was diagnosed with diabetes mellitus and. Location: JAPAN , 82 years of age, After Starsis was administered, patient had the following side effects: abdominal pain upper, nausea (What is nausea?). During the same period patient was treated with OMEPRAZOLE (10 Mg, Unk) (View Omeprazole Review and Omeprazole Label ), CONIEL (4 Mg, Unk) (View Coniel Review and Coniel Label ), URSO 250 (200 Mg, Unk) (View Urso 250 Review and Urso 250 Label ), PROHEPARUM (Unk, Unk) (View Proheparum Review and Proheparum Label ), KAMAG G (1 G, Unk) (View Kamag G Review and Kamag G Label ), MICARDIS (40 Mg, Unk) (View Micardis Review and Micardis Label ).

5621595-6 | Blood Alkaline Phosphatase Increased, Blood Potassium Increased, Blood Urea Increased, C-reactive Protein Increased, Hyperkalaemia, Liver Disorder, Surgery
on Feb 01, 2008 Female patient from JAPAN , 85 years of age, was diagnosed with diabetes mellitus and was treated with Starsis (View Usage). Patient experienced the following unwanted or unexpected effects: blood alkaline phosphatase increased, blood potassium increased, blood urea increased, c-reactive protein increased, hyperkalaemia, liver disorder, surgery (What is surgery?). Starsis dosage: 270mg/day. During the same period patient was treated with GASTER (View Gaster Review and Gaster Label ), MUCOSTA (Unk, Unk) (View Mucosta Review and Mucosta Label ), GLAKAY (Unk, Unk) (View Glakay Review and Glakay Label ), ROCALTROL (Unk, Unk) (View Rocaltrol Review and Rocaltrol Label ), FLOMOX (Unk, Unk) (View Flomox Review and Flomox Label ), UNASYN (Unk, Unk) (View Unasyn Review and Unasyn Label ), AMLODIPINE BESYLATE (Unk, Unk) (View Amlodipine Besylate Review and Amlodipine Besylate Label ), INSULIN (Unk, Unk) (View Insulin Review and Insulin Label ).


5597132-1 | Blood Potassium Increased
on Jan 11, 2008 Female patient from JAPAN , 85 years of age, was diagnosed with diabetes mellitus and was treated with Starsis (View Usage). Patient had the following side effects: blood potassium increased. Starsis dosage: Unk, Unk. During the same period patient was treated with GASTER (View Gaster Review and Gaster Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), GLAKAY (View Glakay Review and Glakay Label ), ROCALTROL (View Rocaltrol Review and Rocaltrol Label ), FLOMOX (View Flomox Review and Flomox Label ).

5581323-X | Abdominal Pain Upper, Nausea
Patient was taking Starsis (View Usage). After Starsis was administered, patient had the following side effects: abdominal pain upper, nausea (What is nausea?) on Dec 27, 2007 from JAPAN Additional patient health information: Female patient , 82 years of age, was diagnosed with diabetes mellitus and. Starsis dosage: 180 Mg, Qd. During the same period patient was treated with OMEPRAZOLE (10 Mg, Unk) (View Omeprazole Review and Omeprazole Label ), CONIEL (4 Mg, Unk) (View Coniel Review and Coniel Label ), URSO 250 (200 Mg, Unk) (View Urso 250 Review and Urso 250 Label ), PROHEPARUM (Unk, Unk) (View Proheparum Review and Proheparum Label ), KAMAG G (1 G, Unk) (View Kamag G Review and Kamag G Label ), MICARDIS (40 Mg, Unk) (View Micardis Review and Micardis Label ).

5575983-7 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Urea Increased, Eosinophilia, Liver Disorder, Lymphocyte Stimulation Test Positive
Adverse event was reported on Dec 19, 2007 by a Male patient taking Starsis (View Usage) (Dosage: 270 Mg/day) was diagnosed with type 2 diabetes mellitus and. Location: JAPAN , 57 years of age, Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood urea increased, eosinophilia, liver disorder, lymphocyte stimulation test positive. During the same period patient was treated with BASEN (0.6 Mg/day) (View Basen Review and Basen Label ), NOVORAPID (View Novorapid Review and Novorapid Label ), GLIMICRON (120 Mg, Unk) (View Glimicron Review and Glimicron Label ). Patient was hospitalized.

5524927-2 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Liver Disorder
on Nov 15, 2007 Male patient from JAPAN , 57 years of age, was diagnosed with diabetes mellitus and was treated with Starsis (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, liver disorder. Starsis dosage: 270 Mg/day. During the same period patient was treated with BASEN (0.6 Mg/day) (View Basen Review and Basen Label ). Patient was hospitalized.

5228388-2 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Gamma-glutamyltransferase Increased, Liver Disorder
on Jan 30, 2007 Female patient from JAPAN , 64 years of age, was diagnosed with diabetes mellitus and was treated with Starsis (View Usage). After Starsis was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, liver disorder. Starsis dosage: 270 Mg/day. During the same period patient was treated with GLIMICRON (20 Mg, Unk) (View Glimicron Review and Glimicron Label ), MEVALOTIN (5 Mg, Unk) (View Mevalotin Review and Mevalotin Label ), VOGLIBOSE (View Voglibose Review and Voglibose Label ).

5212122-6 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Gamma-glutamyltransferase Increased, Liver Disorder
Patient was taking Starsis (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, liver disorder on Jan 10, 2007 from JAPAN Additional patient health information: Female patient , 64 years of age, was diagnosed with diabetes mellitus and. Starsis dosage: 270 Mg/day. During the same period patient was treated with GLIMICRON (20 Mg, Unk) (View Glimicron Review and Glimicron Label ), MEVALOTIN (5 Mg, Unk) (View Mevalotin Review and Mevalotin Label ), VOGLIBOSE (View Voglibose Review and Voglibose Label ).

5141933-0 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Weight Decreased
Adverse event was reported on Aug 30, 2006 by a Male patient taking Starsis (View Usage) (Dosage: 270 Mg/day) . Location: JAPAN , 47 years of age, Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, weight decreased. During the same period patient was treated with LIPITOR (10 Mg/day) (View Lipitor Review and Lipitor Label ), SANOREX (1 Mg/day) (View Sanorex Review and Sanorex Label ), VOGLIBOSE (0.6 Mg, Unk) (View Voglibose Review and Voglibose Label ), NU LOTAN (50 Mg, Unk) (View Nu-lotan Review and Nu-lotan Label ).

5109238-1 | Depressed Level Of Consciousness, Hypertension, Hypoglycaemia, Vomiting
on May 27, 2006 Male patient from JAPAN , 74 years of age, was diagnosed with diabetes mellitus, hypertension, pruritus, hyperphosphataemia, hyperuricaemia and was treated with Starsis (View Usage). After Starsis was administered, patient had the following side effects: depressed level of consciousness, hypertension, hypoglycaemia, vomiting. Starsis dosage: 270 Mg/day. During the same period patient was treated with BASEN (0.9 Mg, Unk) (View Basen Review and Basen Label ), NORVASC (10 Mg, Unk) (View Norvasc Review and Norvasc Label ), BLOPRESS (16 Mg, Unk) (View Blopress Review and Blopress Label ), OLMESARTAN MEDOXOMIL (20 Mg, Unk) (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ), CARDENALIN (2 Mg, Unk) (View Cardenalin Review and Cardenalin Label ), POLARAMINE (18 Mg, Unk) (View Polaramine Review and Polaramine Label ), TANKARU (3 G, Unk) (View Tankaru Review and Tankaru Label ), ALLOPURINOL (100 Mg, Unk) (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

5096325-X | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Weight Decreased
on Aug 30, 2006 Male patient from JAPAN , 47 years of age, was treated with Starsis (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, weight decreased. Starsis dosage: 270 Mg/day. During the same period patient was treated with LIPITOR (10 Mg/day) (View Lipitor Review and Lipitor Label ), SANOREX (1 Mg/day) (View Sanorex Review and Sanorex Label ), VOGLIBOSE (0.6 Mg, Unk) (View Voglibose Review and Voglibose Label ), NU LOTAN (50 Mg, Unk) (View Nu-lotan Review and Nu-lotan Label ).

5023424-0 | Depressed Level Of Consciousness, Hypertension, Hypoglycaemia, Vomiting
Patient was taking Starsis (View Usage). Patient had the following side effects: depressed level of consciousness, hypertension, hypoglycaemia, vomiting on May 27, 2006 from JAPAN Additional patient health information: Male patient , 74 years of age, was diagnosed with diabetes mellitus, hypertension, pruritus, hyperphosphataemia, hyperuricaemia and. Starsis dosage: 270 Mg/day. During the same period patient was treated with BASEN (0.9 Mg, Unk) (View Basen Review and Basen Label ), NORVASC (10 Mg, Unk) (View Norvasc Review and Norvasc Label ), BLOPRESS (16 Mg, Unk) (View Blopress Review and Blopress Label ), OLMETEC (20 Mg, Unk) (View Olmetec Review and Olmetec Label ), CARDENALIN (2 Mg, Unk) (View Cardenalin Review and Cardenalin Label ), POLARAMINE (18 Mg, Unk) (View Polaramine Review and Polaramine Label ), TANKARU (3 G, Unk) (View Tankaru Review and Tankaru Label ), ALLOPURINOL (100 Mg, Unk) (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

4944510-7 | Diabetes Mellitus Inadequate Control, Haematocrit Decreased, Haemoglobin Decreased, Pancytopenia, Platelet Count Decreased, Red Blood Cell Count Decreased, White Blood Cell Count Decreased
Adverse event was reported on Feb 20, 2006 by a Female patient taking Starsis (View Usage) (Dosage: 270 Mg/day) was diagnosed with diabetes mellitus, pancytopenia and. Location: JAPAN , 53 years of age, After Starsis was administered, patient had the following side effects: diabetes mellitus inadequate control, haematocrit decreased, haemoglobin decreased, pancytopenia, platelet count decreased, red blood cell count decreased, white blood cell count decreased. During the same period patient was treated with MITIGLINIDE (30 Mg/day) (View Mitiglinide Review and Mitiglinide Label ), FERROMIA (50 Mg, Unk) (View Ferromia Review and Ferromia Label ), MELBIN (View Melbin Review and Melbin Label ), GLIMICRON (20 Mg, Unk) (View Glimicron Review and Glimicron Label ).

4941503-0 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Hepatic Function Abnormal
on Aug 24, 2005 Female patient from JAPAN , 76 years of age, was diagnosed with diabetes mellitus, gastritis, hypertension, diarrhoea and was treated with Starsis (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, hepatic function abnormal. Starsis dosage: 270 Mg, Qd. During the same period patient was treated with SEVEN EP (View Seven Ep Review and Seven Ep Label ), AMLODIN (5 Mg, Unk) (View Amlodin Review and Amlodin Label ), LOPEMIN (3 Mg, Unk) (View Lopemin Review and Lopemin Label ), OPIUM TINCTURE (1.5 Ml, Unk) (View Opium Tincture Review and Opium Tincture Label ), STOGAR (20 Mg, Unk) (View Stogar Review and Stogar Label ). Patient was hospitalized.

4927816-7 | Diabetes Mellitus Inadequate Control, Haematocrit Decreased, Pancytopenia, Red Blood Cell Count Decreased, White Blood Cell Count Decreased
on Feb 20, 2006 Female patient from JAPAN , 53 years of age, was diagnosed with diabetes mellitus and was treated with Starsis (View Usage). Patient had the following side effects: diabetes mellitus inadequate control, haematocrit decreased, pancytopenia, red blood cell count decreased, white blood cell count decreased. Starsis dosage: 270 Mg/day. During the same period patient was treated with MITIGLINIDE (30 Mg/day) (View Mitiglinide Review and Mitiglinide Label ), FERROMIA (50 Mg, Unk) (View Ferromia Review and Ferromia Label ), MELBIN (View Melbin Review and Melbin Label ).

4915707-7 | Acute Myocardial Infarction, Blood Glucose Decreased, Depressed Level Of Consciousness, Hypoglycaemia, Hypoglycaemic Coma, Treatment Noncompliance
Patient was taking Starsis (View Usage). After Starsis was administered, patient had the following side effects: acute myocardial infarction, blood glucose decreased, depressed level of consciousness, hypoglycaemia, hypoglycaemic coma, treatment noncompliance on Oct 26, 2005 from JAPAN Additional patient health information: Female patient , 67 years of age, was diagnosed with diabetes mellitus and. Starsis dosage: 90 Mg, Tid. Patient was hospitalized.

4915706-5 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Hepatic Function Abnormal
Adverse event was reported on Aug 24, 2005 by a Female patient taking Starsis (View Usage) (Dosage: 270 Mg, Qd) was diagnosed with diabetes mellitus, gastritis, hypertension, diarrhoea and. Location: JAPAN , 76 years of age, Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, hepatic function abnormal. During the same period patient was treated with SEVEN EP (View Seven Ep Review and Seven Ep Label ), AMLODIN (5 Mg, Unk) (View Amlodin Review and Amlodin Label ), LOPEMIN (3 Mg, Unk) (View Lopemin Review and Lopemin Label ), OPIUM TINCTURE (1.5 Ml, Unk) (View Opium Tincture Review and Opium Tincture Label ), STOGAR (20 Mg, Unk) (View Stogar Review and Stogar Label ). Patient was hospitalized.

4911857-X | Blood Glucose Decreased, Hypoglycaemia
on Oct 26, 2005 Female patient from JAPAN , 67 years of age, was diagnosed with diabetes mellitus and was treated with Starsis (View Usage). Patient had the following side effects: blood glucose decreased, hypoglycaemia. Starsis dosage: 270 Mg, Qd.

4871663-1 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Hepatic Function Abnormal
on Dec 28, 2005 Male patient from JAPAN , 71 years of age, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with Starsis (View Usage). After Starsis was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal. Starsis dosage: 270 Mg/day. During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), LASIX (View Lasix Review and Lasix Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ), WARFARIN (View Warfarin Review and Warfarin Label ).

4838371-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Cholelithiasis
Patient was taking Starsis (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, cholelithiasis on Oct 05, 2005 from JAPAN Additional patient health information: Male patient , 82 years of age, . Starsis dosage: 60 Mg, Qd. During the same period patient was treated with NORVASC (0.5 Mg, Unk) (View Norvasc Review and Norvasc Label ), MEVALOTIN (10 Mg, Unk) (View Mevalotin Review and Mevalotin Label ), CLEANAL (1.2 G, Unk) (View Cleanal Review and Cleanal Label ), DIGOSIN (0.25 Mg, Unk) (View Digosin Review and Digosin Label ).

4825428-7 | Blood Pressure Increased, Cardiac Failure, Cardiomegaly, Cardiomyopathy, Chest Pain, Feeling Abnormal, Heart Rate Increased, Oxygen Saturation Decreased, Pulmonary Congestion
Adverse event was reported on Oct 07, 2005 by a Male patient taking Starsis (View Usage) (Dosage: 15 Mg, Qd) was diagnosed with diabetes mellitus non-insulin-dependent, congestive cardiomyopathy, vasodilation procedure, cardiac failure, thrombosis prophylaxis and. Location: JAPAN , 43 years of age, Patient had the following side effects: blood pressure increased, cardiac failure, cardiomegaly, cardiomyopathy (What is cardiomyopathy?), chest pain (What is chest pain?), feeling abnormal, heart rate increased, oxygen saturation decreased, pulmonary congestion. During the same period patient was treated with ARTIST (1.25 Mg, Unk) (View Artist Review and Artist Label ), FRANDOL (2 Df, Unk) (View Frandol Review and Frandol Label ), TORSEMIDE (4 Mg, Unk) (View Torsemide Review and Torsemide Label ), ASPIRIN (100 Mg, Unk) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

4816551-1 | Blood Glucose Decreased, Hypoglycaemia, Loss Of Consciousness
on Oct 26, 2005 Female patient from JAPAN , 67 years of age, was diagnosed with diabetes mellitus and was treated with Starsis (View Usage). After Starsis was administered, patient had the following side effects: blood glucose decreased, hypoglycaemia, loss of consciousness. Starsis dosage: 270 Mg, Qd.

4811391-1 | Blood Pressure Increased, Cardiac Failure, Cardiomegaly, Chest Pain, Feeling Abnormal, Heart Rate Increased, Oxygen Saturation Decreased, Pulmonary Congestion, Ventricular Extrasystoles
on Oct 07, 2005 Male patient from JAPAN , 43 years of age, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with Starsis (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure increased, cardiac failure, cardiomegaly, chest pain (What is chest pain?), feeling abnormal, heart rate increased, oxygen saturation decreased, pulmonary congestion, ventricular extrasystoles. Starsis dosage: 15 Mg, Qd. During the same period patient was treated with ARTIST (1.25 Mg, Unk) (View Artist Review and Artist Label ), FRANDOL (2 Df, Unk) (View Frandol Review and Frandol Label ), TORSEMIDE (4 Mg, Unk) (View Torsemide Review and Torsemide Label ), ASPIRIN (100 Mg, Unk) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

4801107-7 | Blood Pressure Increased, Feeling Abnormal, Ventricular Extrasystoles
Patient was taking Starsis (View Usage). Patient had the following side effects: blood pressure increased, feeling abnormal, ventricular extrasystoles on Oct 07, 2005 from JAPAN Additional patient health information: Male patient , 43 years of age, was diagnosed with diabetes mellitus non-insulin-dependent and. Starsis dosage: 15 Mg, Qd. During the same period patient was treated with ARTIST (2.5 Mg, Unk) (View Artist Review and Artist Label ), FRANDOL (2 Df, Unk) (View Frandol Review and Frandol Label ), TORSEMIDE (4 Mg, Unk) (View Torsemide Review and Torsemide Label ), ASPIRIN (100 Mg, Unk) (View Aspirin Review and Aspirin Label ).

4798904-3 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Cholelithiasis
Adverse event was reported on Oct 05, 2005 by a Male patient taking Starsis (View Usage) (Dosage: 60 Mg, Qd) . Location: JAPAN , 82 years of age, After Starsis was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, cholelithiasis.

4794373-8 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Bilirubin Conjugated Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Blood Cholinesterase Increased, Blood Lactate Dehydrogenase Increased, Gamma-glutamyltransferase Increased
on Sep 16, 2005 Female patient from JAPAN , 78 years of age, was diagnosed with diabetes mellitus non-insulin-dependent, osteoporosis (What is osteoporosis?), gastritis, hepatic cirrhosis, anxiety (What is anxiety?), constipation (What is constipation?) and was treated with Starsis (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, blood cholinesterase increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased. Starsis dosage: 180 Mg, Qd. During the same period patient was treated with ROCALTROL (0.5 Ug, Qd) (View Rocaltrol Review and Rocaltrol Label ), SELBEX (150 Mg, Qd) (View Selbex Review and Selbex Label ), PROHEPARUM (3 Df, Qd) (View Proheparum Review and Proheparum Label ), DEPAS (0.5 Mg, Qd) (View Depas Review and Depas Label ), MAGNESIUM OXIDE (1 G, Qd) (View Magnesium Oxide Review and Magnesium Oxide Label ), TOUGHMAC E (3 Df, Qd) (View Toughmac E Review and Toughmac E Label ). Patient was hospitalized.

4786002-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Hepatic Function Abnormal
on Aug 24, 2005 Female patient from JAPAN , 76 years of age, was diagnosed with diabetes mellitus and was treated with Starsis (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal. Starsis dosage: 270 Mg, Qd. Patient was hospitalized.

4777410-6 | Aspartate Aminotransferase Increased
Patient was taking Starsis (View Usage). After Starsis was administered, patient had the following side effects: aspartate aminotransferase increased on Sep 16, 2005 from JAPAN Additional patient health information: Female patient , 78 years of age, was diagnosed with diabetes mellitus non-insulin-dependent and. Starsis dosage: 180 Mg, Unk. During the same period patient was treated with ROCALTROL (0.5 Ug, Qd) (View Rocaltrol Review and Rocaltrol Label ), SELBEX (150 Mg, Qd) (View Selbex Review and Selbex Label ), PROHEPARUM (3 Df, Qd) (View Proheparum Review and Proheparum Label ), DEPAS (0.5 Mg, Qd) (View Depas Review and Depas Label ), MAGNESIUM OXIDE (1 G, Qd) (View Magnesium Oxide Review and Magnesium Oxide Label ), TOUGHMAC E (3 Df, Qd) (View Toughmac E Review and Toughmac E Label ). Patient was hospitalized.

4714491-X | Alanine Aminotransferase Increased, Hepatic Function Abnormal
Adverse event was reported on Jul 08, 2005 by a Female patient taking Starsis (View Usage) (Dosage: 270 Mg/day) was diagnosed with diabetes mellitus and. Location: JAPAN , 74 years of age, Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, hepatic function abnormal. During the same period patient was treated with NU LOTAN (25 Mg/day) (View Nu-lotan Review and Nu-lotan Label ), CIBENOL (200 Mg/day) (View Cibenol Review and Cibenol Label ), MONTELUKAST SODIUM (10 Mg/day) (View Montelukast Sodium Review and Montelukast Sodium Label ).

4641542-3 | Blood Creatinine Increased, Blood Potassium Increased, Blood Urea Increased, Hyperkalaemia, Renal Disorder
on Mar 18, 2005 Male patient from , 52 years of age, was diagnosed with diabetes mellitus, hyperlipidaemia and was treated with Starsis (View Usage). Patient had the following side effects: blood creatinine increased, blood potassium increased, blood urea increased, hyperkalaemia, renal disorder. Starsis dosage: 270 Mg, Qd. During the same period patient was treated with LIPANTIL (150 Mg/day) (View Lipantil Review and Lipantil Label ), CLARITIN (10 Mg/day) (View Claritin Review and Claritin Label ).

4635119-3 | Blood Creatinine Increased, Blood Potassium Increased, Hyperkalaemia, Renal Disorder
on Mar 18, 2005 Male patient from , 52 years of age, was diagnosed with diabetes mellitus, hyperlipidaemia and was treated with Starsis (View Usage). After Starsis was administered, patient had the following side effects: blood creatinine increased, blood potassium increased, hyperkalaemia, renal disorder. Starsis dosage: 270 Mg, Qd. During the same period patient was treated with LIPANTIL (150 Mg/day) (View Lipantil Review and Lipantil Label ), CLARITIN (10 Mg/day) (View Claritin Review and Claritin Label ).

4628279-1 | Acidosis, Blood Creatinine Increased, Blood Urea Increased, Dehydration, Diarrhoea, Hypoglycaemia, Renal Failure
Patient was taking Starsis (View Usage). Patient experienced the following unwanted or unexpected effects: acidosis, blood creatinine increased, blood urea increased, dehydration, diarrhoea, hypoglycaemia, renal failure on Feb 25, 2005 from Additional patient health information: Male patient , 50 years of age, was diagnosed with diabetes mellitus, atrial fibrillation (What is atrial fibrillation?), gastritis, hypertension, hyperthyroidism and. Starsis dosage: 90 Mg, Tid. During the same period patient was treated with VASOLAN (80 Mg, Unk) (View Vasolan Review and Vasolan Label ), LIPITOR (View Lipitor Review and Lipitor Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), OMEPRAL (View Omepral Review and Omepral Label ), WARFARIN SODIUM (2 Mg, Qd) (View Warfarin Sodium Review and Warfarin Sodium Label ), ZANTAC (300 Mg, Qd) (View Zantac Review and Zantac Label ), LASIX (20 Mg, Qd) (View Lasix Review and Lasix Label ), METHIMAZOLE (25 Mg, Unk) (View Methimazole Review and Methimazole Label ). Patient was hospitalized.

4626954-6 | Blood Creatinine Increased, Blood Potassium Increased, Hyperkalaemia, Renal Disorder
Adverse event was reported on Mar 18, 2005 by a Male patient taking Starsis (View Usage) (Dosage: 270 Mg, Qd) was diagnosed with diabetes mellitus, hyperlipidaemia and. Location: , 52 years of age, Patient had the following side effects: blood creatinine increased, blood potassium increased, hyperkalaemia, renal disorder. During the same period patient was treated with LIPANTIL (150 Mg/day) (View Lipantil Review and Lipantil Label ), CLARITIN (10 Mg/day) (View Claritin Review and Claritin Label ).

4622927-8 | Liver Disorder, Rhabdomyolysis
on Mar 10, 2005 Male patient from , 84 years of age, was diagnosed with diabetes mellitus and was treated with Starsis (View Usage). After Starsis was administered, patient had the following side effects: liver disorder, rhabdomyolysis. Starsis dosage: 270 Mg, Qd. During the same period patient was treated with NU LOTAN (25 Mg, Unk) (View Nu-lotan Review and Nu-lotan Label ), ALOSITOL (100 Mg, Unk) (View Alositol Review and Alositol Label ). Patient was hospitalized.

4621778-8 | Acidosis, Blood Creatinine Increased, Blood Urea Increased, Dehydration, Diarrhoea, Hypoglycaemia, Renal Failure, Renal Impairment
on Feb 25, 2005 Male patient from , 50 years of age, was diagnosed with diabetes mellitus, atrial fibrillation (What is atrial fibrillation?), gastritis, hypertension, hyperthyroidism and was treated with Starsis (View Usage). Patient experienced the following unwanted or unexpected effects: acidosis, blood creatinine increased, blood urea increased, dehydration, diarrhoea, hypoglycaemia, renal failure, renal impairment. Starsis dosage: 90 Mg, Tid. During the same period patient was treated with VASOLAN (80 Mg, Unk) (View Vasolan Review and Vasolan Label ), LIPITOR (View Lipitor Review and Lipitor Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), OMEPRAL (View Omepral Review and Omepral Label ), WARFARIN SODIUM (2 Mg, Qd) (View Warfarin Sodium Review and Warfarin Sodium Label ), ZANTAC (300 Mg, Qd) (View Zantac Review and Zantac Label ), LASIX (20 Mg, Qd) (View Lasix Review and Lasix Label ), METHIMAZOLE (25 Mg, Unk) (View Methimazole Review and Methimazole Label ). Patient was hospitalized.

4613872-2 | Hyperkalaemia
Patient was taking Starsis (View Usage). Patient had the following side effects: hyperkalaemia on Mar 18, 2005 from Additional patient health information: Male patient , 52 years of age, was diagnosed with diabetes mellitus and. Starsis dosage: 270 Mg, Qd. During the same period patient was treated with LIPANTIL (150 Mg/day) (View Lipantil Review and Lipantil Label ), CLARITIN (10 Mg/day) (View Claritin Review and Claritin Label ).

4597435-3 | Blood Creatinine Increased, Diarrhoea, Hypoglycaemia, Renal Impairment
Adverse event was reported on Feb 25, 2005 by a Male patient taking Starsis (View Usage) (Dosage: 90 Mg, Tid) was diagnosed with diabetes mellitus, atrial fibrillation (What is atrial fibrillation?), gastritis, hypertension, hyperthyroidism and. Location: , 50 years of age, After Starsis was administered, patient had the following side effects: blood creatinine increased, diarrhoea, hypoglycaemia, renal impairment. During the same period patient was treated with VASOLAN (80 Mg, Unk) (View Vasolan Review and Vasolan Label ), LIPITOR (View Lipitor Review and Lipitor Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), OMEPRAL (View Omepral Review and Omepral Label ), WARFARIN (2 Mg, Qd) (View Warfarin Review and Warfarin Label ), ZANTAC (300 Mg, Qd) (View Zantac Review and Zantac Label ), LASIX (20 Mg, Qd) (View Lasix Review and Lasix Label ), METHIMAZOLE (25 Mg, Unk) (View Methimazole Review and Methimazole Label ). Patient was hospitalized.